Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study

By Shinsako Keiko   Mizuno Tomoyuki   Terada Tomohiro   Watanabe Jun   Kamba Tomomi   Nakamura Eijiro   Ogawa Osamu   Inui Ken-ichi  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 512-514

Springer Publishing Company

Access to resources Recommend Favorite

5fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma

By                    

Oncology Letters, Vol. 3, Iss. 6, 2012-01 ,pp. : 1195-1202

Spandidos Publications

Access to resources Recommend Favorite

Sorafenib Therapy for Metastatic Renal Carcinoma in Patients with Low Cardiac Ejection Fraction: Report of Two Cases and Literature Review

By Kamada Pratima   Dudek Arkadiusz Z.  

Cancer Investigation, Vol. 28, Iss. 5, 2010-05 ,pp. : 501-504

Informa Healthcare

Access to resources Recommend Favorite

Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma

By Trask Peter  

Journal of Cancer Survivorship, Vol. 5, Iss. 3, 2011-09 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

Salvage Therapy with Oral Etoposide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By Gedlicka C.   Kornfehl J.   Turhani D.   Burian M.   Formanek M.  

Cancer Investigation, Vol. 24, Iss. 3, 2006-05 ,pp. : 252-255

Informa Healthcare

Access to resources Recommend Favorite